Geode Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Buy |
|
|||||
|
2025
Q1 | $2.85M | Buy |
|
|||||
|
2024
Q4 | $2.15M | Buy |
|
|||||
|
2024
Q3 | $1.79M | Buy |
|
|||||
|
2024
Q2 | $891K | Sell |
|
|||||
|
2024
Q1 | $3.03M | Buy |
|
|||||
|
2023
Q4 | $15.2M | Buy |
|
|||||
|
2023
Q3 | $18M | Buy |
|
|||||
|
2023
Q2 | $20.2M | Buy |
|
|||||
|
2023
Q1 | $26.1M | Buy |
|
|||||
|
2022
Q4 | $31.6M | Buy |
|
|||||
|
2022
Q3 | $17.9M | Buy |
|
|||||
|
2022
Q2 | $4.46M | Buy |
|
|||||
|
2022
Q1 | $2.44M | Buy |
|